29241-16-5

Basic information

• Product Name: 6-nitrobenzo[d][1,2,3]thiadiazole
• Synonyms: 6-nitrobenzo[d][1,2,3]thiadiazole
• CAS NO: 29241-16-5
• Molecular Formula: C₆H₃N₃O₂S
• Molecular Weight: 181.17192
• Mol File: 29241-16-5.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 329.7°Cat760mmHg
• Flash Point: 153.2°C
• Appearance: /
• Density: 1.627g/cm³
• Vapor Pressure: 0.000336mmHg at 25°C
• Refractive Index: 1.746
• CAS DataBase Reference: 6-nitrobenzo[d][1,2,3]thiadiazole(CAS DataBase Reference)
• NIST Chemistry Reference: 6-nitrobenzo[d][1,2,3]thiadiazole(29241-16-5)
• EPA Substance Registry System: 6-nitrobenzo[d][1,2,3]thiadiazole(29241-16-5)

Safety Data

• Hazardous Substances Data: 29241-16-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C6H3N3O2S/c10-9(11)4-1-2-5-6(3-4)12-8-7-5/h1-3H

Upstream product

• 2942-06-5 6-nitrobenzo[d]thiazole 
• 58381-87-6 2-[(2-amino-5-nitrophenyl)dithio]-4-nitrophenylamine 
• 23451-98-1 2-amino-5-nitrobenzenethiol 

Downstream Products

• 1426152-53-5 1-(benzo[d][1,2,3]thiadiazol-6-yl)-3-(2-oxo-2-(piperidin-1-yl)ethyl)urea 
• 1426152-52-4 C₁₅H₁₁FN₄O₂S 
• 1426152-51-3 C₁₅H₁₈N₄O₂S 
• 1426152-50-2 C₁₅H₂₀N₄O₂S 
• 1426152-49-9 C₁₅H₁₃FN₄O₂S 
• 1426152-48-8 C₁₅H₁₃FN₄O₂S 
• 1426152-47-7 C₁₅H₁₂F₂N₄OS 
• 1426152-46-6 C₁₅H₁₄N₄O₂S 
• 1426152-75-1 C₁₆H₁₅FN₄OS 
• 1426152-74-0 C₁₅H₁₂N₄O₂S 
• 1426152-73-9 C₁₅H₁₁F₃N₄OS 
• 1426152-72-8 C₁₄H₁₁FN₄OS 
• 1426152-71-7 C₁₅H₁₁F₃N₄OS 
• 1426152-70-6 C₁₅H₁₁N₅OS 

Relevant articles and documents

Histone lysine methyltransferase NSD2 inhibiting small-molecule compound and application thereof

The invention belongs to the field of chemical medicine and particularly relates to a histone lysine methyltransferase NSD2 inhibiting small-molecule compound. A general formula of the small-moleculecompound is as shown in the specification. According to

SELECTIVE ANDROGEN RECEPTOR MODULATORS

This invention provides compounds of formula I, pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable excipient, methods of modulating the androgen receptor, methods of treating diseases beneficially treated by an androgen receptor modulator (e.g., sarcopenia, prostate cancer, contraception, type 2 diabetes related disorders or diseases, anemia, depression, and renal disease) and processes for making compounds and intermediates useful in the preparation of same.